 | Up a level |
Number of items: 1.
Scheffier, Matthias, Boa, Marc Christiaan Allardt, Sos, Martin L., Heukamp, Lukas Carl, Nogova, Lucia, Koenig, Katharina, Gardizi, Masyar, Mattonet, Christian, Kahraman, Manz, Kobe, Ca, Boellaard, Ronald, Lammertsma, Adriaan A., Persigehl, Thorsten, Engel-Riedel, Walburga, Toepelt, Karin, Neumaier, Bernd, Buettner, Reinhard, Zander, Thomas and Wolf, Juergen (2014). MIMEB: A phase II trial to evaluate FDG-PET/FLT-PET, DCE-MRI and molecular biomarkers for early prediction of nonprogression in patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755